Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Hematologic”

13,784 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 13,784 results

Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Early research (Phase 1)Looking for participantsNCT06367673
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Testing effectiveness (Phase 2)Study completedNCT00030394
What this trial is testing

Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Looking for participantsNCT06920251
What this trial is testing

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Early research (Phase 1)Study completedNCT04813653
What this trial is testing

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Tel-Aviv Sourasky Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Looking for participantsNCT06564545
What this trial is testing

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University 276
Large-scale testing (Phase 3)Study completedNCT03123939
What this trial is testing

Phase III B in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Study completedNCT00743288
What this trial is testing

Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncotherapeutics 40
Large-scale testing (Phase 3)Study completedNCT01208766
What this trial is testing

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 1,503
Testing effectiveness (Phase 2)Study completedNCT00042822
What this trial is testing

FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04266795
What this trial is testing

Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)
Takeda 164
Not applicableLooking for participantsNCT05045963
What this trial is testing

Impact of Aminoglycosides in Hypotensive Septic Oncology Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSepticemia
M.D. Anderson Cancer Center 319
Testing effectiveness (Phase 2)Study completedNCT00388193
What this trial is testing

Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt's Lymphoma
PETHEMA Foundation 20
Testing effectiveness (Phase 2)Study completedNCT00036738
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more
Fred Hutchinson Cancer Center 28
Very early researchWithdrawnNCT03921515
What this trial is testing

Skin Immunity Sample Collection Involving Blisters and Biopsies

Who this might be right for
Hyper-Immunoglobulin E. Syndrome (HEIS)Chronic Granulomatous Disease (CGD)
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT04883125
What this trial is testing

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL PositiveCML, Chronic Phase
Mansoura University 90
Post-approval studies (Phase 4)UnknownNCT02389920
What this trial is testing

Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib

Who this might be right for
Leukemia, Chronic Myeloid
Samsung Medical Center 40
Not applicableStudy completedNCT00001560
What this trial is testing

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Who this might be right for
Acquired Immunodeficiency SyndromeKaposi's SarcomaLeukemia+3 more
National Cancer Institute (NCI) 24
Load More Results